Selleck Chemicals - Model A2847 -Lendalizumab (Anti-Complement C5)

Lendalizumab (Anti-Complement C5) is a proprietary antibody that targets the complement protein C5a with potential immunomodulating and anti-inflammatory activities. MW : 146.02 KD.